Dhananjay Pal

ORCID: 0000-0002-3019-2213
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Drug Transport and Resistance Mechanisms
  • Advanced Drug Delivery Systems
  • Paranormal Experiences and Beliefs
  • Amino Acid Enzymes and Metabolism
  • Pharmacological Effects and Toxicity Studies
  • Biofield Effects and Biophysics
  • HIV/AIDS drug development and treatment
  • Nanoparticle-Based Drug Delivery
  • Retinal Diseases and Treatments
  • Ocular Surface and Contact Lens
  • RNA Interference and Gene Delivery
  • Quantum Mechanics and Applications
  • Neonatal Health and Biochemistry
  • Pharmacogenetics and Drug Metabolism
  • EEG and Brain-Computer Interfaces
  • Cytomegalovirus and herpesvirus research
  • Biotin and Related Studies
  • Metabolism and Genetic Disorders
  • Crystallization and Solubility Studies
  • Systemic Lupus Erythematosus Research
  • Folate and B Vitamins Research
  • X-ray Diffraction in Crystallography
  • Herpesvirus Infections and Treatments
  • Advancements in Transdermal Drug Delivery
  • Vitamin C and Antioxidants Research

West Bengal University of Animal and Fishery Sciences
2023

University of Missouri–Kansas City
2012-2021

Maulana Abul Kalam Azad University of Technology, West Bengal
2007-2015

Indian Institute of Engineering Science and Technology, Shibpur
2013-2014

University of Kentucky
2011

University of Kansas
1997-2005

Augusta University
2004

Kansas City University
2003

The University of Texas Medical Branch at Galveston
1992

University of Calcutta
1986-1990

The purpose of this study was to evaluate in vitro interactions commercially obtained pure herbal constituents with p-glycoprotein P-gp and cytochrome P-450 3A4 (CYP3A4) activities, which can further modulate the transcellular transport metabolism kinetics orally administered drugs. Caco-2 cells grown presence 0.25 μmol/L 1α,25-dihydroxy vitamin D3 multidrug-resistant 1 (MDR1) transfected MDCK were used as models effect purified (quercetin, hypericin, hyperforin from St. John's wort,...

10.1097/01.mjt.0000101827.94820.22 article EN American Journal of Therapeutics 2004-01-01

Efflux pumps such as P-glycoprotein (P-gp; MDR1) are believed to be a major barrier drug delivery. The purpose of this work was determine whether cornea and corneal epithelial cells expresses the functionally active P-gp efflux pump.Cultured rabbit primary (rPCECs) cell line (Statens Seruminstitut [SIRC] cells) were selected model. Rhodamine-123 (Rho-123), substrate, used probe. To confirm gene expression, RT-PCR performed with appropriate pairs primers for human MDR1. Subcloning,...

10.1167/iovs.02-1142 article EN Investigative Ophthalmology & Visual Science 2003-06-24

10.1016/j.ijpharm.2007.02.036 article EN International Journal of Pharmaceutics 2007-03-08

Topical drug administration for back of the eye delivery is extremely challenging due to presence protection mechanisms and physiological barriers. Self-assembled polymeric nanomicelles have emerged as promising vehicles delivery. Apart from serving an inert nanocarrier therapeutic agents, are known bypass mononuclear phagocytic system (MPS) efflux transporters thereby improving bioavailability. In this investigation, a highly efficacious biotinylated lipid prodrug cyclic cidofovir...

10.1021/acs.molpharmaceut.7b00128 article EN Molecular Pharmaceutics 2017-05-04
Coming Soon ...